False
June 19, 2026
As BIO 2026 approaches, industry experts weigh in on the conversations likely to dominate the floor – from AI and funding pressures to manufacturing readiness, regulatory uncertainty, and the challenge of turning innovation into real-world impact
7 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
June 15, 2026
The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement
1 min read
June 15, 2026
Why patient voices must shape rare disease innovation
4 min read
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
June 11, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy
June 10, 2026
As new rules take hold, what does “good AI practice” look like in drug development?
6 min read
June 9, 2026
Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody
4 min read
June 8, 2026
Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine
10 min read
June 8, 2026
Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts
5 min read
June 5, 2026
The $787M financing points to a new global architecture in biotech
5 min read
June 4, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies
1 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
